ToxDB: pathway-level interpretation of drug-treatment data

C. Hardt, M. E. Beber, A. Rasche, A. Kamburov, D. G. Hebels, J. C. Kleinjans, R. Herwig*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Motivation: Extensive drug treatment gene expression data have been generated in order to identify biomarkers that are predictive for toxicity or to classify compounds. However, such patterns are often highly variable across compounds and lack robustness. We and others have previously shown that supervised expression patterns based on pathway concepts rather than unsupervised patterns are more robust and can be used to assess toxicity for entire classes of drugs more reliably. Results: We have developed a database, ToxDB, for the analysis of the functional consequences of drug treatment at the pathway level. We have collected 2694 pathway concepts and computed numerical response scores of these pathways for 437 drugs and chemicals and 7464 different experimental conditions. ToxDB provides functionalities for exploring these pathway responses by offering tools for visualization and differential analysis allowing for comparisons of different treatment parameters and for linking this data with toxicity annotation and chemical information.
Original languageEnglish
Article numberbaw052
JournalDatabase-The Journal of Biological Databases and Curation
Volume2016
DOIs
Publication statusPublished - 13 Apr 2016

Fingerprint

Dive into the research topics of 'ToxDB: pathway-level interpretation of drug-treatment data'. Together they form a unique fingerprint.

Cite this